Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 6/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.70 |
| ▸ | HTT | P42858 | 2/20 | 0.70 |
| ▸ | BLVRB | P30043 | 2/20 | 0.70 |
| ▸ | PDE4A | P27815 | 1/20 | 0.70 |
| ▸ | KDR | P35968 | 1/20 | 0.70 |
| ▸ | RECQL | P46063 | 2/20 | 0.67 |
| ▸ | BLM | P54132 | 2/20 | 0.67 |
| ▸ | APP | P05067 | 1/20 | 0.67 |
| ▸ | THRB | P10828 | 1/20 | 0.67 |
| ▸ | PHLPP2 | Q6ZVD8 | 4/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.62 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29359461 | 1.00 | TDP1 (1.00) | TDP1ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL133647 | 1.00 | TDP1 (1.00) | TDP1ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL7033973 | 0.98 | TDP1 (0.97) | TDP1ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL7033980 | 0.98 | TDP1 (0.97) | TDP1ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL7033984 | 0.98 | TDP1 (0.97) | TDP1ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL3101571 | 0.88 | ALDH1A1 (0.78) | TDP1ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL3101576 | 0.88 | ALDH1A1 (0.78) | TDP1ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL29481568 | 0.87 | ALDH1A1 (0.77) | TDP1ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL4047509 | 0.87 | ALDH1A1 (0.77) | TDP1ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL4051923 | 0.87 | ALDH1A1 (0.77) | TDP1ALDH1A1SMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 571 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3757168-B1 | ROOM-TEMPERATURE-CURABLE ORGANOPOLYSILOXANE COMPOSITION, STRUCTURE, AND METHOD FOR ASSESSING CURED STATE OF SAID COMPOSITION | SHINETSU CHEMICAL CO (JP) | 2025-03-26 | — | — | EP | claimed |
| US-20250092439-A1 | LYOPHILISED NUCLEIC ACID AMPLIFICATION REACTION COMPOSITION | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2025-03-20 | — | — | US | claimed |
| US-20250065568-A1 | METHOD, APPARATUS, AND SYSTEM FOR SUPPORT MATERIAL REMOVAL FROM A 3D-PRINTED OBJECT | ORYX ADDITIVE INC (US) | 2025-02-27 | — | — | US | claimed |
| US-20250042781-A1 | ECO-FRIENDLY METHOD, APPARATUS, AND SYSTEM FOR PRECIPITATION AND COLLECTION OF DISSOLVED SUPPORT MATERIAL | ORYX ADDITIVE INC (US) | 2025-02-06 | — | — | US | claimed |
| EP-4463564-A1 | LYOPHILISED NUCLEIC ACID AMPLIFICATION REACTION COMPOSITION | Imperial College Innovations Limited (GB) | 2024-11-20 | — | — | EP | claimed |
| EP-4444531-A1 | METHOD, APPARATUS, AND SYSTEM FOR SUPPORT MATERIAL REMOVAL FROM A 3D-PRINTED OBJECT | Oryx Additive, Inc. (US) | 2024-10-16 | — | — | EP | claimed |
| EP-4444546-A1 | ECO-FRIENDLY METHOD, APPARATUS, AND SYSTEM FOR PRECIPITATION AND COLLECTION OF DISSOLVED SUPPORT MATERIAL | Oryx Additive, Inc. (US) | 2024-10-16 | — | — | EP | claimed |
| WO-2023131803-A1 | LYOPHILISED NUCLEIC ACID AMPLIFICATION REACTION COMPOSITION | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2023-07-13 | — | — | WO | claimed |
| WO-2023108087-A1 | METHOD, APPARATUS, AND SYSTEM FOR SUPPORT MATERIAL REMOVAL FROM A 3D-PRINTED OBJECT | ORYX ADDITIVE, INC. (US) | 2023-06-15 | — | — | WO | claimed |
| WO-2023108088-A1 | ECO-FRIENDLY METHOD, APPARATUS, AND SYSTEM FOR PRECIPITATION AND COLLECTION OF DISSOLVED SUPPORT MATERIAL | ORYX ADDITIVE, INC. (US) | 2023-06-15 | — | — | WO | claimed |
| US-20090157025-A1 | Wetness Sensors | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2009-06-18 | — | — | US | claimed |
| WO-2009033135-A1 | UNIVERSAL DRINKING ADAPTER FOR BEVERAGE BOTTLES TO ALLOW FOR LIQUID CONSUMPTION AND DEVICES AND KITS FOR DETERMINING SMALL MOLECULES, METAL IONS, ENDOTOXINS, AND BACTERIA FOUND IN MILK, AND METHODS OF USE THEREOF | SUREMILK, LLC. (US) | 2009-03-12 | — | — | WO | claimed |
| US-20080244837-A1 | Cosmetic article and process for dry dyeing keratin materials | L'OREAL S.A. (FR) | 2008-10-09 | — | — | US | claimed |
| EP-1964539-A1 | Cosmetic article for dyeing dry hair, its use, method of implementing said article | L'Oréal (FR) | 2008-09-03 | — | — | EP | claimed |
| US-20080148496-A1 | Dyeing of in Particular Human Keratin Materials by Dry Thermal Transfer of a Direct Dye, Composition Comprising the Said Dye and Its Method of Preparation | L'OREAL S.A. (FR) | 2008-06-26 | — | — | US | claimed |
| US-20060173058-A1 | Kcnq channel modulating compounds and their pharmaceutical use | NEUROSEARCH A/S (DK) | 2006-08-03 | — | — | US | claimed |
| EP-1603858-A2 | KCNQ CHANNEL MODULATING COMPOUNDS AND THEIR PHARMACEUTICAL USE | NeuroSearch A/S (DK) | 2005-12-14 | — | — | EP | claimed |
| WO-2004080377-A2 | KCNQ CHANNEL MODULATING COMPOUNDS AND THEIR PHARMACEUTICAL USE | NEUROSEARCH A/S (DK) | 2004-09-23 | — | — | WO | claimed |
| US-20030087451-A1 | Acid test kit | MAINSTREAM ENGINEERING CORP. | 2003-05-08 | — | — | US | claimed |
| WO-1996033394-A1 | ACID TEST KIT | MAINSTREAM ENGINEERING CORPORATION (US) | 1996-10-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080244837-A1 | Cosmetic article and process for dry dyeing keratin materials | KRT18, CUTA, DSG1 | TDP1 3293/4885ALDH1A1 844/4885SMN1; SMN2 4813/4885 |
| US-20060173058-A1 | Kcnq channel modulating compounds and their pharmaceutical use | KCNQ1, KCNQ2, KCNQ5 | TDP1 4573/4885ALDH1A1 4394/4885SMN1; SMN2 2692/4885 |
| US-20080148496-A1 | Dyeing of in Particular Human Keratin Materials by Dry Thermal Transfer of a Direct Dye, Composition Comprising the Said Dye and Its Method of Preparation | KRT18, IK, DSG1 | TDP1 3318/4885ALDH1A1 911/4885SMN1; SMN2 4721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.